Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. (Q51690286)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. |
scientific article published in January 2003 |
Statements
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. (English)
1 reference
Jonathan Corren
1 reference
Thomas Casale
1 reference
Yamo Deniz
1 reference
Mark Ashby
1 reference
1 January 2003
1 reference
111
1 reference
1
1 reference
87-90
1 reference